Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Jan;170(1):20-8.
doi: 10.1001/jamapediatrics.2015.2757.

Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study

Ulla Uusitalo  1 , Xiang Liu  1 , Jimin Yang  1 , Carin Andrén Aronsson  2 , Sandra Hummel  3 , Martha Butterworth  1 , Åke Lernmark  2 , Marian Rewers  4 , William Hagopian  5 , Jin-Xiong She  6 , Olli Simell  7 , Jorma Toppari  8 , Anette G Ziegler  3 , Beena Akolkar  9 , Jeffrey Krischer  1 , Jill M Norris  10 , Suvi M Virtanen  11 ; TEDDY Study Group
Collaborators, Affiliations
Multicenter Study

Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study

Ulla Uusitalo et al. JAMA Pediatr. 2016 Jan.

Abstract

Importance: Probiotics have been hypothesized to affect immunologic responses to environmental exposures by supporting healthy gut microbiota and could therefore theoretically be used to prevent the development of type 1 diabetes mellitus (T1DM)-associated islet autoimmunity.

Objective: To examine the association between supplemental probiotic use during the first year of life and islet autoimmunity among children at increased genetic risk of T1DM.

Design, setting, and participants: In this ongoing prospective cohort study that started September 1, 2004, children from 6 clinical centers, 3 in the United States (Colorado, Georgia/Florida, and Washington) and 3 in Europe (Finland, Germany, and Sweden), were followed up for T1DM-related autoantibodies. Blood samples were collected every 3 months between 3 and 48 months of age and every 6 months thereafter to determine persistent islet autoimmunity. Details of infant feeding, including probiotic supplementation and infant formula use, were monitored from birth using questionnaires and diaries. We applied time-to-event analysis to study the association between probiotic use and islet autoimmunity, stratifying by country and adjusting for family history of type 1 diabetes, HLA-DR-DQ genotypes, sex, birth order, mode of delivery, exclusive breastfeeding, birth year, child's antibiotic use, and diarrheal history, as well as maternal age, probiotic use, and smoking. Altogether 8676 infants with an eligible genotype were enrolled in the follow-up study before the age of 4 months. The final sample consisted of 7473 children with the age range of 4 to 10 years (as of October 31, 2014).

Exposures: Early intake of probiotics.

Main outcomes and measures: Islet autoimmunity revealed by specific islet autoantibodies.

Results: Early probiotic supplementation (at the age of 0-27 days) was associated with a decreased risk of islet autoimmunity when compared with probiotic supplementation after 27 days or no probiotic supplementation (hazard ratio [HR], 0.66; 95% CI, 0.46-0.94). The association was accounted for by children with the DR3/4 genotype (HR, 0.40; 95% CI, 0.21-0.74) and was absent among other genotypes (HR, 0.97; 95% CI, 0.62-1.54).

Conclusions and relevance: Early probiotic supplementation may reduce the risk of islet autoimmunity in children at the highest genetic risk of T1DM. The result needs to be confirmed in further studies before any recommendation of probiotics use is made.

PubMed Disclaimer

Figures

Figure
Figure
Islet Autoimmunity Risk by First Probiotic Exposure Age of the Child
See this image and copyright information in PMC

Comment in

References

    1. Hara N, Alkanani AK, Ir D, et al. The role of the intestinal microbiota in type 1 diabetes. Clin Immunol. 2013;146(2):112–119. - PubMed
    1. Kaplan JL, Shi HN, Walker WA. The role of microbes in developmental immunologic programming. Pediatr Res. 2011;69(6):465–472. - PubMed
    1. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–1273. - PMC - PubMed
    1. Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8(2):110–120. doi:10.1038/cmi. - PMC - PubMed
    1. Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57(10):2555–2562. - PMC - PubMed

Publication types

Grants and funding